The direction of mental health care for the elderly

Postgraduate Medical Journal

Volumn 80, Issue 942, 2004, Pages 187-189

  Barker, A ^a  

^a The Fairway   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ATTITUDE; CONFUSION; DEMOGRAPHY; ELDERLY CARE; GOVERNMENT; HEALTH BEHAVIOR; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; MEDICAL EXPERT; MEDICAL INFORMATICS; MEDICAL PRACTICE; MEDICAL STAFF; MEDICAL TECHNOLOGY; MENTAL DISEASE; MENTAL HEALTH CARE; MENTAL PATIENT; ORTHOSTATIC HYPOTENSION; PARKINSONISM; POPULATION; POPULATION RESEARCH; PREDICTION; PROSTHESIS; REVIEW; SEDATION; SIDE EFFECT; SOCIAL WORK; TARDIVE DYSKINESIA; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; DRUG THERAPY; GREAT BRITAIN; HEALTH POLICY; HEALTH SERVICES FOR THE AGED; HUMANS; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MIDDLE AGED; PROFESSIONAL PRACTICE;

EID: 2342422313     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2002.003731     Document Type: Review

References (15)

1. Office for National Statistics. Census 2001: national report for England and Wales. London: Office for National Statistics, 2002.
2. Office for National Statistics. Population Trends 91. London: Office for National Statistics, 1998.
3. Kitwood T. Dementia reconsidered: the person comes first. Maidenhead: Open University Press, 1997.
4. Rice K, Warner N. Breaking the bad news: what do psychiatrists tell patients with dementia about their illness? Int J Geriatr Psychiatry 1994;9:467-71.
5. Audit Commission. Forget me not: mental health services for older people. London: Audit Commission, 2000.
6. Stationery Office. The NHS plan: a plan for investment, a plan for reform. London: Stationery Office, 2000.
7. Department of Health. National service framework for older people. London: Department of Health, 2001.
8. Department of Health. Improvement, expansion and reform - the next 3 years. Priorities and planning framework 2003-2006. London: Department of Health, 2002.
9. Holmes J, Bentley K, Cameron I. Between two stools: psychiatric services for older people in general hospitals. Report of a UK survey. Leeds: University of Leeds, 2002.
10. National Institute for Clinical Excellence. Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease. Technology appraisal guidance No 19. London: National Institute for Clinical Excellence, 2001.
11. Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999;400:173-7.
12. Janus C, Pearson J, McLourin J, et al. A β peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000;408:979-82.
13. Morgan D, Diamond DM, Gottschall PE, et al. A β peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000;408:982-5.
14. Birmingham K, Frantz S. Set back to Alzheimer vaccine studies. Nature Med 2002;8:199-200.
15. James AR, Nicoll D, Wilkinson C, et al. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nature Med 2003;9:448-52.